獣医用CROの世界市場:タイプ別(臨床試験、毒性学、市場認可&規制サポート、その他)、用途別(犬、猫、その他)、エンドユーザー別(腫瘍学、感染症、神経学、その他)

◆英語タイトル:Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support and Others), Application (Dogs, Cats, and Others), End User (Oncology, Infectious Diseases, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2019 - 2026
◆商品コード:AMR20FE009
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2019年12月9日
◆ページ数:181
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,370 ⇒換算¥563,850見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥677,250見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥944,475見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、獣医用CROの世界市場について調べ、イントロダクション、エグゼクティブサマリー、市場概要、タイプ別(臨床試験、毒性学、市場認可&規制サポート、その他)分析、用途別(犬、猫、その他)分析、エンドユーザー別(腫瘍学、感染症、神経学、その他)分析、地域別分析、競争状況、企業概要などを総合的、多面的にまとめております。

・イントロダクション
・エグゼクティブサマリ-
・市場概要
・獣医用CROの世界市場:タイプ別(臨床試験、毒性学、市場認可&規制サポート、その他)
・獣医用CROの世界市場:用途別(犬、猫、その他)
・獣医用CROの世界市場:エンドユーザー別(腫瘍学、感染症、神経学、その他)
・獣医用CROの世界市場:地域別
・競争状況
・企業概要
【レポートの概要】

The global veterinary CRO market was valued at $485.5 million in 2018, and is expected to reach $894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026.
Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases.
The factors that boost the growth of the veterinary CRO market include surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in prevalence of various diseases among companion animal acts as a major factor that contributes toward the growth of the market. However, lack of standardization in veterinary CROs is a factor that restrains the growth of the market. Conversely, surge in awareness related to animal healthcare across the globe is expected to provide lucrative opportunities in the market during the forecast period.
The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, the market is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global veterinary CRO market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative service types facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
• By Service Type
o Clinical Trials
o Toxicology
o Market Authorization & Regulatory Support
o Others

• By Animal Type
o Dogs
o Cats
o Others

• By Indication
o Oncology
o Infectious Disease
o Neurology
o Others

• By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest Of LAMEA

List of key players profiled in the report:
• Charles River Laboratories, Inc.
• Clinvet
• KLIFOVET AG
• Löhlein & Wolf Vet Research
• Oncovet Clinical Research
• ONDAX Scientific
• Triveritas
• Veterinary Research Management (VRM) Ltd
• VetPharm, Inc.
• VETSPIN SRL

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• AlcheraBio
• Likarda

【レポートの目次】

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study

2.1.1. Top Impacting Factors
2.1.2. Top Investment Pockets

2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Porter’S Five Forces Analysis

3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Thereat of New Entrants
3.2.4. Threat of Substitutes
3.2.5. Intensity of Competitive Rivalry

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Surge In Ownership of Companion Animals
3.3.1.2. Rise In Animal Health Expenditure
3.3.1.3. Increase In Prevalence of Various Diseases Among Companion Animals

3.3.2. Restraint

3.3.2.1. Lack of Standardization In Veterinary Cros

3.3.3. Opportunity

3.3.3.1. Surge In Awareness Related To Animal Healthcare

3.3.4. Impact Analysis

Chapter 4: Veterinary Cro Market, By Service Type

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Clinical Trials

4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis By Country

4.3. Toxicology

4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis By Country

4.4. Market Authorization And Regulatory Support

4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis By Country

4.5. Others

4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis By Country

Chapter 5: Veterinary Cro Market, By Animal Type

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Dogs

5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis By Country

5.3. Cats

5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis By Country

5.4. Others

5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis By Country

Chapter 6: Veterinary Cro Market, By Indication

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Oncology

6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis By Country

6.3. Infectious Disease

6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis By Country

6.4. Neurology

6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis By Country

6.5. Others

6.5.1. Market Size And Forecast, By Region
6.5.2. Market Analysis By Country

Chapter 7: Veterinary Cro Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends And Opportunities
7.2.2. Market Analysis By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Market Size And Forecast, By Service Type
7.2.2.1.2. U.S. Market Size And Forecast, By Animal Type
7.2.2.1.3. U.S. Market Size And Forecast, By Indication

7.2.2.2. Canada

7.2.2.2.1. Canada Market Size And Forecast, By Service Type
7.2.2.2.2. Canada Market Size And Forecast, By Animal Type
7.2.2.2.3. Canada Market Size And Forecast, By Indication

7.2.2.3. Mexico

7.2.2.3.1. Mexico Market Size And Forecast, By Service Type
7.2.2.3.2. Mexico Market Size And Forecast, By Animal Type
7.2.2.3.3. Mexico Market Size And Forecast, By Indication

7.2.3. North America Market Size And Forecast, By Service Type
7.2.4. North America Market Size And Forecast, By Animal Type
7.2.5. North America Market Size And Forecast, By Indication

7.3. Europe

7.3.1. Key Market Trends And Opportunities
7.3.2. Market Analysis By Country

7.3.2.1. Germany

7.3.2.1.1. Germany Market Size And Forecast, By Service Type
7.3.2.1.2. Germany Market Size And Forecast, By Animal Type
7.3.2.1.3. Germany Market Size And Forecast, By Indication

7.3.2.2. France

7.3.2.2.1. France Market Size And Forecast, By Service Type
7.3.2.2.2. France Market Size And Forecast, By Animal Type
7.3.2.2.3. France Market Size And Forecast, By Indication

7.3.2.3. Uk

7.3.2.3.1. Uk Market Size And Forecast, By Service Type
7.3.2.3.2. Uk Market Size And Forecast, By Animal Type
7.3.2.3.3. Uk Market Size And Forecast, By Indication

7.3.2.4. Italy

7.3.2.4.1. Italy Market Size And Forecast, By Service Type
7.3.2.4.2. Italy Market Size And Forecast, By Animal Type
7.3.2.4.3. Italy Market Size And Forecast, By Indication

7.3.2.5. Spain

7.3.2.5.1. Spain Market Size And Forecast, By Service Type
7.3.2.5.2. Spain Market Size And Forecast, By Animal Type
7.3.2.5.3. Spain Market Size And Forecast, By Indication

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe Market Size And Forecast, By Service Type
7.3.2.6.2. Rest of Europe Market Size And Forecast, By Animal Type
7.3.2.6.3. Rest of Europe Market Size And Forecast, By Indication

7.3.3. Europe Market Size And Forecast, By Service Type
7.3.4. Europe Market Size And Forecast, By Animal Type
7.3.5. Europe Market Size And Forecast, By Indication

7.4. Asia-Pacific

7.4.1. Key Market Trends And Opportunities
7.4.2. Market Analysis By Country

7.4.2.1. Japan

7.4.2.1.1. Japan Market Size And Forecast, By Service Type
7.4.2.1.2. Japan Market Size And Forecast, By Animal Type
7.4.2.1.3. Japan Market Size And Forecast, By Indication

7.4.2.2. China

7.4.2.2.1. China Market Size And Forecast, By Service Type
7.4.2.2.2. China Market Size And Forecast, By Animal Type
7.4.2.2.3. China Market Size And Forecast, By Indication

7.4.2.3. Australia

7.4.2.3.1. Australia Market Size And Forecast, By Service Type
7.4.2.3.2. Australia Market Size And Forecast, By Animal Type
7.4.2.3.3. Australia Market Size And Forecast, By Indication

7.4.2.4. Rest of Asia-Pacific

7.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Service Type
7.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Animal Type
7.4.2.4.3. Rest of Asia-Pacific Market Size And Forecast, By Indication

7.4.3. Asia-Pacific Market Size And Forecast, By Service Type
7.4.4. Asia-Pacific Market Size And Forecast, By Animal Type
7.4.5. Asia-Pacific Market Size And Forecast, By Indication

7.5. Lamea

7.5.1. Key Market Trends And Opportunities
7.5.2. Market Analysis By Country

7.5.2.1. Brazil

7.5.2.1.1. Brazil Market Size And Forecast, By Service Type
7.5.2.1.2. Brazil Market Size And Forecast, By Animal Type
7.5.2.1.3. Brazil Market Size And Forecast, By Indication

7.5.2.2. South Africa

7.5.2.2.1. South Africa Market Size And Forecast, By Service Type
7.5.2.2.2. South Africa Market Size And Forecast, By Animal Type
7.5.2.2.3. South Africa Market Size And Forecast, By Indication

7.5.2.3. Saudi Arabia

7.5.2.3.1. Saudi Arabia Market Size And Forecast, By Service Type
7.5.2.3.2. Saudi Arabia Market Size And Forecast, By Animal Type
7.5.2.3.3. Saudi Arabia Market Size And Forecast, By Indication

7.5.2.4. Rest of Lamea

7.5.2.4.1. Rest of Lamea Market Size And Forecast, By Service Type
7.5.2.4.2. Rest of Lamea Market Size And Forecast, By Animal Type
7.5.2.4.3. Rest of Lamea Market Size And Forecast, By Indication

7.5.3. Lamea Market Size And Forecast, By Service Type
7.5.4. Lamea Market Size And Forecast, By Animal Type
7.5.5. Lamea Market Size And Forecast, By Indication

Chapter 8: Competitive Landscape

8.1. Introduction

8.1.1. Market Player Positioning, 2018

8.2. Top Winning Strategies And Key Developments
8.3. Competitive Dashboard
8.4. Competitive Heatmap

Chapter 9: Company Profiles

9.1. Charles River Laboratories, Inc.

9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves And Developments

9.2. Clinvet

9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Key Strategic Moves And Developments

9.3. Klifovet Ag

9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio

9.4. Löhlein & Wolf Vet Research

9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Key Strategic Moves And Developments

9.5. Oncovet Clinical Research

9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio

9.6. Ondax Scientific

9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Key Strategic Moves And Developments

9.7. Triveritas

9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio

9.8. Veterinary Research Management (Vrm) Ltd

9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio

9.9. Vetpharm, Inc.

9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio

9.10. Vetspin Srl

9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio

List of Tables

Table 01. North America And Europe Veterinary Cro Market, By Service Type, 2016–2026 ($Million)
Table 02. Veterinary Cro Market For Clinical Trials, By Region, 2019–2026 ($Million)
Table 03. Veterinary Cro Market For Toxicology Market, By Region, 2019–2026 ($Million)
Table 04. Veterinary Cro Market For Market Authorization And Regulatory Support Market, By Region 2019–2026 ($Million)
Table 05. Veterinary Cro Market For Others Market, By Region, 2019–2026 ($Million)
Table 06. North America And Europe Veterinary Cro Market, By Animal Type, 2016–2026 ($Million)
Table 07. Veterinary Cro Market For Dogs, By Region, 2019–2026 ($Million)
Table 08. Veterinary Cro Market For Cats, By Region, 2019–2026 ($Million)
Table 09. Veterinary Cro Market For Others, By Region, 2019–2026 ($Million)
Table 10. North America And Europe Veterinary Cro Market, By Indication, 2016–2026 ($Million)
Table 11. Veterinary Cro Market For Oncology, By Region, 2019–2026 ($Million)
Table 12. Veterinary Cro Market For Infectious Disease Market, By Region, 2019–2026 ($Million)
Table 13. Veterinary Cro Market For Neurology, By Region, 2019–2026 ($Million)
Table 14. Veterinary Cro Market For Others, By Region 2019–2026 ($Million)
Table 15. Veterinary Cro Market, By Region, 2018–2026 ($Million)
Table 16. North America Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 17. U.S. Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 18. U.S. Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 19. U.S. Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 20. Canada Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 21. Canada Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 22. Canada Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 23. Mexico Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 24. Mexico Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 25. Mexico Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 26. North America Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 27. North America Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 28. North America Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 29. Europe Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 30. Germany Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 31. Germany Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 32. Germany Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 33. France Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 34. France Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 35. France Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 36. Uk Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 37. Uk Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 38. Uk Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 39. Italy Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 40. Italy Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 41. Italy Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 42. Spain Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 43. Spain Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 44. Spain Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 45. Rest of Europe Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 46. Rest of Europe Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 47. Rest of Europe Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 48. Europe Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 49. Europe Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 50. Europe Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 51. Asia-Pacific Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 52. Japan Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 53. Japan Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 54. Japan Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 55. China Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 56. China Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 57. China Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 58. Australia Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 59. Australia Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 60. Australia Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 61. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 62. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 63. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 64. Asia-Pacific Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 65. Asia-Pacific Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 66. Asia-Pacific Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 67. Lamea Veterinary Cro Market Revenue, By Country, 2019–2026 ($Million)
Table 68. Brazil Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 69. Brazil Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 70. Brazil Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 71. South Africa Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 72. South Africa Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 73. South Africa Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 74. Saudi Arabia Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 75. Saudi Arabia Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 76. Saudi Arabia Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 77. Rest of Lamea Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 78. Rest of Lamea Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 79. Rest of Lamea Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 80. Lamea Veterinary Cro Market Revenue, By Service Type, 2019–2026 ($Million)
Table 81. Lamea Veterinary Cro Market Revenue, By Animal Type, 2019–2026 ($Million)
Table 82. Lamea Veterinary Cro Market Revenue, By Indication, 2019–2026 ($Million)
Table 83. Charles River Laboratories, Inc.: Company Snapshot
Table 84. Charles River Laboratories, Inc.: Operating Segments
Table 85. Charles River Laboratories, Inc. Plc: Product Portfolio
Table 86. Clinvet: Company Snapshot
Table 87. Clinvet Inc.: Operating Segments
Table 88. Clinvet Inc.: Product Portfolio
Table 89. Klifovet Ag: Company Snapshot
Table 90. Klifovet Ag: Operating Segments
Table 91. Klifovet Ag: Product Portfolio:
Table 92. Löhlein & Wolf Vet Research: Company Snapshot
Table 93. Löhlein & Wolf Vet Research: Operating Segments
Table 94. Löhlein & Wolf Vet Research: Product Portfolio
Table 95. Oncovet Clinical Research: Company Snapshot
Table 96. Oncovet Clinical Research: Operating Segments
Table 97. Oncovet Clinical Research: Product Portfolio
Table 98. Ondax Scientific: Company Snapshot
Table 99. Ondax Scientific: Operating Segments
Table 100. Ondax Scientific: Product Portfolio
Table 101. Triveritas: Company Snapshot
Table 102. Triveritas: Operating Segments
Table 103. Triveritas: Product Portfolio
Table 104. (Vrm): Company Snapshot
Table 105. Vrm: Operating Segments
Table 106. Vrm: Product Portfolio
Table 107. Vetpharm, Inc.: Company Snapshot
Table 108. Vetpharm, Inc.: Product Segments
Table 109. Vetpharm, Inc.: Product Portfolio
Table 110. Vetspin Srl.: Company Snapshot
Table 111. Vetspin Srl.: Operating Segments
Table 112. Vetspin Srl: Product Portfolio

List of Figures

Figure 01. Top Impacting Factors
Figure 02. Top Investment Pockets
Figure 03. North America And Europe Veterinary Cro Market Segmentation
Figure 04. Low Bargaining Power of Buyers
Figure 05. Low Bargaining Power of Suppliers
Figure 06. Low Threat of New Entrants
Figure 08. Moderate Competitive Rivalry
Figure 09. U.S. Pet Industry Expenditure, 2007–2017 ($Billion)
Figure 10. Impact Analyses
Figure 11. Comparative Share Analysis of Veterinary Cro Market For Clinical Trials, By Country, 2018 & 2026 (%)
Figure 12. Comparative Share Analysis of Veterinary Cro Market For Toxicology, By Country, 2018 & 2026 (%)
Figure 13. Comparative Share Analysis of Veterinary Cro Market For Market Authorization And Regulatory Support Market, By Country, 2018 & 2026 (%)
Figure 14. Comparative Share Analysis of Veterinary Cro Market For Others, By Country, 2018 & 2026 (%)
Figure 15. Comparative Share Analysis of Veterinary Cro Market For Dogs, By Country, 2018 & 2026 (%)
Figure 16. Comparative Share Analysis of Veterinary Cro Market For Cats, By Country, 2018 & 2026 (%)
Figure 17. Comparative Share Analysis of Veterinary Cro Market For Others, By Country, 2018 & 2026 (%)
Figure 18. Comparative Share Analysis of Veterinary Cro Market For Oncology, By Country, 2018 & 2026 (%)
Figure 19. Comparative Share Analysis of Veterinary Cro Market For Infectious Disease, By Country, 2018 & 2026 (%)
Figure 20. Comparative Share Analysis of Veterinary Cro Market For Neurology, By Country, 2018 & 2026 (%)
Figure 21. Comparative Share Analysis of Veterinary Cro Market For Others, By Country, 2018 & 2026 (%)
Figure 22. U.S. Veterinary Cro Market, 2019–2026 ($Million)
Figure 23. Canda Veterinary Cro Market, 2019–2026 ($Million)
Figure 24. Mexico Veterinary Cro Market, 2019–2026 ($Million)
Figure 25. Germany Veterinary Cro Market, 2019–2026 ($Million)
Figure 26. France Veterinary Cro Market, 2019–2026 ($Million)
Figure 27. Uk Veterinary Cro Market, 2019–2026 ($Million)
Figure 28. Italy Veterinary Cro Market, 2019–2026 ($Million)
Figure 29. Spain Veterinary Cro Market, 2019–2026 ($Million)
Figure 30. Rest of Europe Veterinary Cro Market, 2019–2026 ($Million)
Figure 31. Japan Veterinary Cro Market, 2019–2026 ($Million)
Figure 32. China Veterinary Cro Market, 2019–2026 ($Million)
Figure 33. Australia Veterinary Cro Market, 2019–2026 ($Million)
Figure 34. Rest of Asia-Pacific Veterinary Cro Market, 2019–2026 ($Million)
Figure 35. Brazil Veterinary Cro Market, 2019–2026 ($Million)
Figure 36. South Africa Veterinary Cro Market, 2019–2026 ($Million)
Figure 37. Saudi Arabia Veterinary Cro Market, 2019–2026 ($Million)
Figure 38. Rest of Lamea Veterinary Cro Market, 2019–2026 ($Million)
Figure 39. Market Player Positioning, 2018
Figure 40. Competitive Dashboard
Figure 41. Competitive Heatmap of Key Players
Figure 42. Charles River Laboratories Inc.: Net Sales, 2016–2018 ($Million)
Figure 43. Charles River Laboratories Inc.: Revenue Share By Segments, 2018(%)
Figure 44. Charles River Laboratories Inc.: Revenue Share By Region, 2018 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[獣医用CROの世界市場:タイプ別(臨床試験、毒性学、市場認可&規制サポート、その他)、用途別(犬、猫、その他)、エンドユーザー別(腫瘍学、感染症、神経学、その他)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆